The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Subjective Response to Neuroleptics in Schizophrenia
Abstract
Subjective response to neuroleptics in patients with schizophrenia is reviewed in terms of its validity and measurement. Evidence is presented to support a correlation between altered subjective state on neuroleptics, and therapeutic outcome and medication compliance. Factors that have been implicated in the genesis of such altered subjective states include demographics, psychiatric characteristics, type and dose of neuroleptic, extrapyramidal symptoms (particularly akathisia), depressive states, and patients' values and attitudes toward health and illness. Factors that may contribute to lack of interest in researching subjective experiences of schizophrenia patients on medications are reviewed, and methodological improvements in study design are proposed to enhance our understanding of this phenomenon. Such understanding may help us to better appreciate the many factors that contribute to variability of responses to neuroleptic therapy in patients with schizophrenia and also help us to develop more effective treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Hogan, T. P., Awad, A. G., & Eastwood, R. (1983) · Psychological Medicine · doi:10.1017/s0033291700050182 · Cited by 1,028
Self-citationCompliance with therapeutic regimens
Jay, S., Litt, I. F., & Durant, R. H. (1984) · Journal of Adolescent Health Care · doi:10.1016/s0197-0070(84)80012-1 · Cited by 666
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini, R. J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250095013 · Cited by 545
Lyness, W. H., Friedle, N. M., & Moore, K. E. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90040-6 · Cited by 457
Conditioning of food aversions by injections of psychoactive drugs.
Berger, B. D. (1972) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0033316 · Cited by 240
Subjective Response to Antipsychotic Drugs
Van Putten, T. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780270073010 · Cited by 223
Subjective Experiences of Schizophrenia: Toward a New Dynamic Psychiatry--II
Strauss, J. S. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.2.179 · Cited by 196
A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic Patients
Van Putten, T. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810200062009 · Cited by 188
Subjective Response as a Predictor of Outcome in Pharmacotherapy: The Consumer Has a Point
Van Putten, T. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280087009 · Cited by 188
Costs and Benefits of Two Doses of Fluphenazine
Marder, S. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220015002 · Cited by 182
Hogan, T. P., & Awad, A. G. (1992) · Psychological Medicine · doi:10.1017/s0033291700030282 · Cited by 163
Self-citationUtility of the health belief model in examining medication compliance among psychiatric outpatients
Kelly, G. R., Mamon, J. A., & Scott, J. E. (1987) · Social Science & Medicine · doi:10.1016/0277-9536(87)90367-4 · Cited by 144
BRUUN, R. D. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.621 · Cited by 126
Compliance in hypertension: facts and concepts.
Lüscher, T. F., Vetter, H., Siegenthaler, W. E., & Vetter, W. (1985) · PubMed · Cited by 123
Belmaker, R. H., & Wald, D. (1977) · The British Journal of Psychiatry · doi:10.1192/bjp.131.2.222b · Cited by 118
Fluphenazine Dose, Clinical Response, and Extrapyramidal Symptoms During Acute Treatment
Levinson, D. F. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810200069010 · Cited by 97
Alexander, L. (1953) · W.B. Saunders eBooks · doi:10.1037/14489-000 · Cited by 93
Quality of Life of Schizophrenic Patients on Medications and Implications for New Drug Trials
Awad, A. G. (1992) · Psychiatric Services · doi:10.1176/ps.43.3.262 · Cited by 93
Self-citationSchizophrenic and Medical Inpatients as Informed Drug Consumers
Soskis, D. A. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770290127012 · Cited by 87
Neuroleptic noncompliance in schizophrenia
Weiden, P. J., Manevitz, A., Dixon, L. B., Sweeney, J. A., Haas, G. L., & FRANCES, A. J. (1989) · Schizophrenia Research · doi:10.1016/0920-9964(89)90250-8 · Cited by 51
Haloperidol-induced dysphoria in patients with Tourette syndrome
Caine, E. D., & Rj, P. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.9.1216 · Cited by 46
Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome
Russell, K. H., Hagenmeyer-Houser, S. H., & Sanberg, P. R. (1987) · Psychopharmacology · doi:10.1007/bf00690925 · Cited by 42
Drug Therapy in Schizophrenia — Variability of Outcome and Prediction of Response *
Awad, A. G. (1989) · The Canadian Journal of Psychiatry · doi:10.1177/070674378903400716 · Cited by 41
Self-citationSingh, M., & Smith, J. M. (1973) · Comprehensive Psychiatry · doi:10.1016/0010-440x(73)90013-8 · Cited by 33
Early subjective reactions predicting the outcome of hospital treatment in depressive patients
Priebe, S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02875.x · Cited by 23
Giardini, V. (1985) · Psychopharmacology · doi:10.1007/bf00431691 · Cited by 13
Cited by
Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M. F., Simpson, G. M., Stevens, M. C., & Lieberman, J. A. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006986 · Cited by 636
From dopamine to salience to psychosis—Linking biology, pharmacology and phenomenology of psychosis
Kapur, S., Mizrahi, R., & Li, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.01.003 · Cited by 512
Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents
Siris, S. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1379 · Cited by 427
Siris, S. G. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500209 · Cited by 412
Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs
Naber, D., Moritz, S., Lambert, M., Rajonk, F., Holzbach, R., Mass, R., Andresen, B., Frank, P., Rüdiger, H., Reinhard, M., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00166-3 · Cited by 348
Metadata
- Authors
- Awad, A. G.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-01-01
- Volume
- 19
- Issue
- 3
- Pages
- 609-618
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2110091980
- Cited by
- 276
- References
- 28
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.